Otsuki Hideo, Kuwahara Yoshitaka, Nakamura Kenzo, Tsukamoto Takuji
Department of Urology, Nagakubo Hospital.
Nihon Hinyokika Gakkai Zasshi. 2013 Sep;104(5):635-43. doi: 10.5980/jpnjurol.104.635.
To investigate the superiority in 2 radical prostatectomies, we compared the initial results of robotic-assisted radical prostatectomy (RARP) to those of retropubic radical prostatectomy (RRP) performed during the same period at Nagakubo hospital.
The study was conducted on a total of 160 patients having undergone radical prostatectomy from April 2009 to March 2012 (92 patients with RARP and 68 with RRP). We investigated surgical stress, cancer control, functional outcomes and complications in both groups.
Surgical stress; operation time was significantly shorter with RRP; however, blood loss and serum total protein loss were significantly less with RARP. White blood cell count at 2 days after surgery was significantly less with RARP. The rates of analgesic use and SIRS were similar. Although the date on which taking solid meals resumed did not differ, the duration of indwelling urethral catheter and admission period were significantly shorter with RARP. Cancer control; the rates of positive surgical margin were 27.2% and 19.1% with RARP and RRP, respectively (p = 0.24), and biochemical recurrence was seen in 12.0% and 19.1% with RARP and RRP, respectively (p = 0.73), which were not significantly different. Continence; urinary continence outcomes with RARP and RRP were 17% and 4% for urinary continence at discharge (p = 0.01), 1.8 and 3.3 months for no more than one pad per day (p < 0.01), and 4.3 and 6.2 months for pad free (p = 0.03), respectively. Sexual function; erection recovery within 6 mo was only observed with RARP; however, overall recovery rate of erection was 65% and 75% with RARP and RRP, respectively (p = 0.69).
1 case with a rectal injury was seen in both groups, but complication rates were 8.7% and 16.2% with RARP and RRP, respectively (p = 0.22).
In spite of our initial experience of RARP, surgical stress and complications with RARP were considered to be superior to that with RRP. Cancer control and sexual function showed no significant difference between RARP and RRP, however, urinary continence outcome is significantly superior with RARP. Our data suggest that treatment outcome after initial experience with RARP is not inferior to that with RRP, and better results are expected by improving surgical techniques.
为研究两种根治性前列腺切除术的优势,我们比较了长洼医院同期进行的机器人辅助根治性前列腺切除术(RARP)和耻骨后根治性前列腺切除术(RRP)的初步结果。
该研究共纳入了2009年4月至2012年3月期间接受根治性前列腺切除术的160例患者(92例行RARP,68例行RRP)。我们调查了两组患者的手术应激、癌症控制情况、功能结局及并发症。
手术应激;RRP的手术时间明显更短;然而,RARP的失血量和血清总蛋白丢失明显更少。RARP术后2天的白细胞计数明显更低。两组的镇痛药物使用率和全身炎症反应综合征发生率相似。尽管恢复固体饮食的日期无差异,但RARP的尿道导尿管留置时间和住院时间明显更短。癌症控制;RARP和RRP的手术切缘阳性率分别为27.2%和19.1%(p = 0.24),RARP和RRP的生化复发率分别为12.0%和19.1%(p = 0.73),差异均无统计学意义。控尿;RARP和RRP出院时的尿控率分别为17%和4%(p = 0.01),每天使用不超过一片尿垫的时间分别为1.8个月和3.3个月(p < 0.01),完全不用尿垫的时间分别为4.3个月和6.2个月(p = 0.03)。性功能;仅RARP观察到6个月内勃起恢复;然而,RARP和RRP的勃起总体恢复率分别为65%和75%(p = 0.69)。
两组均有1例直肠损伤,但RARP和RRP的并发症发生率分别为8.7%和16.2%(p = 0.22)。
尽管我们对RARP仅有初步经验,但RARP的手术应激和并发症被认为优于RRP。RARP和RRP在癌症控制和性功能方面无显著差异,然而,RARP的尿控结局明显更优。我们的数据表明,RARP初步经验后的治疗效果不劣于RRP,通过改进手术技术有望获得更好的结果。